Cancer Screening Tourism in China: Full Body PET-CT and Tumor Marker Tests

Key Takeaways

• A full body PET-CT scan in China costs approximately $900–$1,500, compared to $4,000–$7,000 in the United States — a 70–80% reduction without sacrificing imaging resolution.
• Top Chinese hospitals operate the same Siemens and GE PET-CT scanners found in major Western medical centers, and radiologists at Fudan-affiliated hospitals read thousands of oncology scans annually.
• Cancer screening packages marketed to international patients vary wildly in quality. Some bundle unnecessary tests. Verifying hospital credentials and radiologist qualifications before booking is not optional — it is essential.
• PET-CT delivers a radiation dose equivalent to 7–10 years of natural background exposure. For asymptomatic people at average cancer risk, the harm of false positives and radiation may outweigh the benefit.

The Problem: Late-Stage Diagnosis Despite Access to Advanced Imaging

Approximately 70% of ovarian cancer cases and nearly 60% of pancreatic cancers are diagnosed at stage III or IV in Western healthcare systems. That is not a failure of technology. It is a failure of timing. The CT and MRI machines exist. The wait times and referral gatekeeping are what delay them. A patient in London with vague abdominal symptoms might wait six weeks for a non-urgent ultrasound. By the time a tumor is visualized, it has already metastasized.

This is the gap that drives a growing number of health-conscious individuals to consider crossing borders for proactive screening. They want the scan now — not after a specialist decides their symptoms are serious enough. China’s hospital infrastructure makes this possible. The country has installed more PET-CT units in the past decade than any other nation. Appointment slots are available within days, not months. And the cost differential is structural, not promotional — it exists because of volume, not because corners are cut.

Who We Are

Our team operates an independent medical information platform. We are not a hospital. We do not employ doctors, interpret scan results, or make clinical recommendations. What we do is connect international patients with the specific Chinese hospitals, departments, and screening programs that match their clinical history and risk profile. We handle the logistics — credential verification, appointment scheduling, language interpretation, and local navigation — so that the only thing you need to focus on is your health. We charge no fees to patients. Our funding comes from the platform itself, which means our guidance is never tied to a particular hospital’s referral targets.

Why Cancer Screening in China Delivers Results

Imaging Volume Builds Diagnostic Speed

A radiologist at a major Chinese teaching hospital — Fudan University Shanghai Cancer Center, for example — may interpret over 8,000 PET-CT studies per year. That is roughly three times the caseload of a typical NHS radiologist. Volume alone does not guarantee accuracy. But when combined with subspecialization, it creates a diagnostic engine that spots subtle findings faster. A 2021 study published in the European Journal of Nuclear Medicine and Molecular Imaging found that Chinese nuclear medicine departments achieved sensitivity rates above 93% for detecting malignant lesions on FDG-PET/CT — comparable to benchmarks set by Memorial Sloan Kettering and MD Anderson. The machines are the same. The difference is throughput.

Technology Parity at a Fraction of the Cost

Walk into the nuclear medicine department of Peking Union Medical College Hospital or Ruijin Hospital in Shanghai and you will see Siemens Biograph Vision PET-CT scanners — the same model used at UCLA and Charité Berlin. The full body PET-CT scan price in China reflects local operating economics, not inferior equipment. Labor costs for technologists and reading physicians are lower. Hospital real estate is less expensive. Patient volume spreads fixed costs across more procedures. The result: a scan that would invoice at $5,200 in a US hospital outpatient setting costs roughly $1,100 in Beijing or Shanghai. That includes the radiopharmaceutical tracer, the scan itself, and a formal written report.

Integrated Tumor Marker Panels Add Clinical Context

A PET-CT scan shows structure and metabolic activity. It does not tell you whether a hot spot is inflammation or malignancy. This is where tumor marker blood tests add value — and where Chinese screening packages can be genuinely useful when designed properly. A tumor marker blood test cost in Shanghai for a standard panel — CEA, CA19-9, CA125, AFP, and CA15-3 — typically ranges from $80 to $150. Combined with imaging, these biomarkers provide a biochemical cross-check. Elevated CA19-9 plus a PET-avid pancreatic lesion carries a different clinical weight than a PET-avid lesion with normal markers. Neither test alone is diagnostic. Together, they reduce the false-positive rate that plagues whole-body screening.

What You Need to Know Before Going Alone

• Hospital Credentialing Is Opaque: China has over 1,200 hospitals that claim to offer PET-CT screening. Fewer than 80 are accredited by the Chinese Society of Nuclear Medicine for oncologic imaging. Independent verification of equipment calibration records and radiologist board certifications is difficult without Chinese-language fluency and familiarity with the regulatory landscape.
• Payment Systems Do Not Accept Foreign Insurance at Most Public Hospitals: Top-tier public hospitals like Zhongshan Hospital or West China Hospital require upfront payment via WeChat Pay, Alipay, or UnionPay bank cards. International credit cards are frequently declined. Out-of-network reimbursement from US or European insurers is possible but requires properly coded Chinese invoices — which hospital billing departments are not obligated to provide in English.
• Results Translation Is a Medical-Legal Problem: A PET-CT report written in Chinese has no legal standing with your home-country physician. Certified medical translation that preserves diagnostic nuance — SUVmax values, anatomical descriptors, impression sections — requires a translator with nuclear medicine terminology training. General translation services routinely introduce errors that alter clinical meaning.

How We Help You Navigate This

These barriers are not accidental. They exist because China’s healthcare system was built for domestic patients, not international visitors. Our role is to bridge that structural gap without pretending the gap does not exist.

Before you travel, we confirm that the hospital you are considering actually performs cancer screening PET-CT for asymptomatic individuals — many Chinese hospitals restrict PET-CT to patients with confirmed cancer diagnoses, and booking a screening package at the wrong facility means arriving to find your appointment canceled. We verify the scanner model, the radiologist’s subspecialty, and whether the tumor marker panel includes the specific biomarkers relevant to your family history and risk factors. During your visit, we provide an in-person medical interpreter who understands the difference between “physiological uptake” and “suspicious lesion.” After you return home, we coordinate certified translation of your report and ensure your images are exported in DICOM format — the universal standard that any radiologist in your home country can load into their PACS system for a second read.

We also maintain an updated directory of China’s top-ranked hospitals by specialty and a curated list of private international hospitals that offer English-language services and direct insurance billing — two separate pathways that serve different patient needs. Our platform helps you understand which one fits your situation before you spend a dollar on airfare.

Frequently Asked Questions